Capstone Investment Advisors, LLC Alkermes Plc. Transaction History
Capstone Investment Advisors, LLC
- $30.4 Billion
- Q3 2024
A detailed history of Capstone Investment Advisors, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 16,704 shares of ALKS stock, worth $516,821. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,704Holding current value
$516,821% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding ALKS
# of Institutions
363Shares Held
182MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$901 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$587 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$402 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$392 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$284 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.08B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...